(19)
(11) EP 1 848 741 A1

(12)

(43) Date of publication:
31.10.2007 Bulletin 2007/44

(21) Application number: 06706900.5

(22) Date of filing: 13.02.2006
(51) International Patent Classification (IPC): 
C07K 16/12(2006.01)
C12N 15/13(2006.01)
C12N 5/10(2006.01)
A61P 31/04(2006.01)
G01N 33/569(2006.01)
A61K 31/7088(2006.01)
 C12N 15/12(2006.01)
C12N 15/79(2006.01)
A61K 39/40(2006.01)
G01N 33/577(2006.01)
C12Q 1/68(2006.01)
(86) International application number:
PCT/EP2006/001289
(87) International publication number:
WO 2006/084758 (17.08.2006 Gazette 2006/33)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 14.02.2005 EP 05003095

(71) Applicant: Kenta Biotech AG
3018 Bern (CH)

(72) Inventors:
  • LANG, Alois, B.
    CH-3627 Helmberg (CH)
  • HORN, Michael, P.
    CH-3604 Thun (CH)
  • IMBODEN, Martin, A.
    CH-3110 Münsingen (CH)
  • ZUERCHER, Adrian
    CH-3012 Bern (CH)

(74) Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät 
Maximilianstrasse 58
80538 München
80538 München (DE)

   


(54) HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR LIPOPOLYSACCHARIDES (LPS) OF THE PSEUDOMONAS AERUGINOSA IATS O11 SEROTYPE